Alzamend Neuro (ALZN) Cash from Investing Activities (2020 - 2025)

Alzamend Neuro has disclosed Cash from Investing Activities across 4 years of filings, most recently posting -$210000.0 for Q2 2025.

• In Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$210000.0; the TTM figure through Apr 2025 stood at -$300000.0 (down 103.74% YoY), while the FY2025 annual figure was -$300000.0, down 103.74% from the prior year.
• Cash from Investing Activities came in at -$210000.0 for Q2 2025 at Alzamend Neuro, down from -$90000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$90000.0 in Q3 2024 to a low of -$210000.0 in Q2 2025.
• Average Cash from Investing Activities over 3 years is -$149081.0, with a median of -$147243.0 recorded in 2023.
• The largest YoY upside for Cash from Investing Activities was 38.88% in 2024 against a maximum downside of 38.88% in 2024.
• Over 3 years, Cash from Investing Activities stood at -$147243.0 in 2023, then jumped by 38.88% to -$90000.0 in 2024, then tumbled by 133.33% to -$210000.0 in 2025.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$210000.0 in Q2 2025, -$90000.0 in Q3 2024, and -$147243.0 in Q3 2023.